Fig. 1From: Prevention of neointimal hyperplasia after coronary artery bypass graft via local delivery of sirolimus and rosuvastatin: network pharmacology and in vivo validationWorkflow of the network pharmacology approach for identifying the mechanism underlying the effects of sirolimus and rosuvastatin in treatment coupled with CABG. PPI protein–protein interaction, CABG coronary artery bypass graftBack to article page